Target intelligence / Profile preview

Gut microbiota–host epithelial surface interaction (null)

Target
null
Molecular classification
Other (microbial community–barrier interface)
01

Overview

The **gut microbiota–host epithelial surface interaction** encompasses the intricate and bidirectional relationship between the vast community of microorganisms residing in the gut (including bacteria, archaea, viruses, and fungi) and the epithelial lining of the gastrointestinal tract. This interaction maintains homeostasis by: - Supporting barrier integrity through regulation of tight junctions, mucin production, and antimicrobial peptide secretion - Modulating immune responses and inflammation - Influencing host metabolism and nutrient absorption via microbial metabolites (e.g., short-chain fatty acids, bile acids, indole derivatives) - Protecting against pathogen invasion Disruption of this relationship (dysbiosis or barrier dysfunction) is linked to diseases such as inflammatory bowel disease, colorectal cancer, infections, and metabolic disorders. Current research focuses on deciphering the molecular mechanisms underlying this crosstalk and developing strategies (such as probiotics, dietary interventions, and microbiome-modifying drugs) to restore or enhance beneficial host–microbe interactions[1][2][3][4][5].

Other names
gut microbiota–epithelium interactionmicrobiota–epithelial cell crosstalkmicrobiota–host interface
02

Mechanism of action

null

03

Biological functions

Regulation of barrier functionImmune system modulationNutrient absorptionMetabolic signaling
04

Disease associations

Inflammatory bowel diseaseColorectal cancerMetabolic disorders (e.g., obesity, diabetes)InfectionOther (broadly implicated in gastrointestinal and systemic diseases)
05

Safety considerations

DysbiosisBarrier dysfunction leading to increased infection riskUnintended immune modulation
06

Biomarkers

Microbial diversity indicesShort-chain fatty acid levelsIntestinal permeability markers (e.g., zonulin)Inflammatory cytokines (e.g., IL-10, TNF-α)

Beyond the preview

Go deeper on Gut microbiota–host epithelial surface interaction (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota–host epithelial surface interaction (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call